FairJourney Bio to present at J.P. Morgan 2026 Healthcare Conference
PORTO, Portugal, 08 January, 2026 – FairJourney Bio (FJBio), a global leader in antibody discovery and development, announced today that its Chief Executive Officer, Dr. Werner Lanthaler, will present at the J.P.
From speed to proof: what happens when innovation meets system maturity
For many founders, the early phase of innovation is familiar territory. A strong idea gains traction, early pilots show promise, and momentum builds around speed — speed to prototype, speed to market, speed to scale.
Nuclera eProtein Discovery System installed at leading Universities in Taiwan
Installations at National Taiwan University and National Cheng Kung University expand Nuclera’s global footprint with first commercial sales in AsiaSystem strengthens Taiwan’s capabilities in protein drug discovery researchCambridge, UK, and Bo
Qureight appoints Dr Steven Bishop as Chief Medical Officer
Change in role from Chief Data Officer reflects Qureight’s continued growth and commercial success in delivering customers’ clinical studies
Why gene therapy matters now
This month, VacZine Analytics, a specialist publisher in healthcare commercial analysis, releases a brand-new situation review on the FDA approved "classical" gene therapy landscape.
Royal College Fellowship joy for three CPFT psychiatrists
Three psychiatrists at Cambridgeshire and Peterborough NHS Foundation Trust (CPFT) have been awarded prestigious Fellowships by the Royal College of Psychiatrists, honouring their outstanding contributions to mental health care and research.
University announces new partnership with AstraZeneca and Beijing municipal parties to accelerate innovations in healthcare
The University of Cambridge, AstraZeneca and Beijing municipal parties (the Beijing Science and Technology Commission and the Beijing Economic and Technological Development Area), have signed an agreement that will enhance collaboration between the University, AstraZeneca and Cambridge and Beijing’s life sciences ecosystems.
Share your views - The Institute for Biomedical Innovation (IBI)
The Institute for Biomedical Innovation (IBI) is a new major investment by the University of Cambridge. Based in the Department of Engineering, the IBI aims to turn early-stage medical technologies into safe, sustainable, clinically ready devices.
UK CFOs upbeat on tech investment and potential for AI to boost productivity for year ahead
More than half of finance chiefs (59%) have become more optimistic over the past 12 months on the potential for AI to boost the performance of their organisation, up from 39% in Q3 of 2024; Almost all of them (96%) expect to see a rise in investment in digital technology and assets by UK companies in the next five years; Corporate risk appetite (15%) has edged up from the lows seen in…
FUJIFILM Irvine Scientific now officially FUJIFILM Biosciences
Rebrand announced in June as part of Fujifilm Life Sciences Group restructuring becomes official
A practical introduction to developing your first product in 2026
If you’ve ever caught yourself circling an idea on a quiet Sunday evening, just as the working week looms, this is likely for you. It’s the idea that pops up when things slow down. The one you scribble into a notes app, then leave untouched.
Why a content audit is one of the most valuable exercises Life Sciences marketing teams overlook
A practical, leadership-level view of how content audits help Life Sciences teams regain clarity, reduce waste and drive stronger commercial impact.
Planning a high ROI webinar: What it really takes to make them work in Life Sciences
Learn what it really takes to plan, execute, and extract lasting ROI from webinars in Life Sciences marketing.
CHITOSE and FUJIFILM Biosciences Form Strategic Alliance to Drive Global Innovation and Biopharmaceutical Manufacturing
Collaboration formed to accelerate biopharmaceutical manufacturing combining high performing CHO-MK cells and GMP-manufactured culture media
Atelerix enters agreement with Cherry Biotech to integrate non-cryogenic transport solutions with advanced organoid models
Partnership brings together proven non-cryogenic biosample preservation technology and advanced organoid models to support growth in preclinical research and biotech sectors
AI, Credit, and Our Human Future: A Question of Capability, Not Just Technology
Visibility and value: As AI-generated outpu
TTP releases new e-book on closing the loop in neuromodulation therapy
TTP has released a new e-book exploring how closed-loop neuromodulation systems can deliver more personalised, responsive therapies. It examines the role of clinically meaningful biomarkers, algorithms, and system-level design in turning real-time sensing into reliable treatment. The e-book draws on TTP’s neurotechnology expertise to help teams de-risk development and accelerate next-generation…
Addenbrooke’s unveils transformed urgent and emergency care spaces and digital innovations for winter
Transformed urgent and emergency care areas and a new digital registration and triage tool are part of plans by teams at Cambridge University Hospitals to help patients get the right treatment in the right place as quickly as possible this winter.
Cambridge Dining Co. - crafting exceptional events
CAMBRIDGE DINING CO. — CRAFTING EXCEPTIONAL EVENTS
New IDTechEx Report: Sensor Market 2026-2036
IDTechEx forecasts that the global sensor market will reach US$250B by 2036 as global mega-trends in mobility, AI, robotics, 6G connectivity and IoT drive sensor demand.
Cambridge NeuroWorks drives UK neurotech forward with launch of nationwide Blue Sky Proof-of-Concept Fund
Cambridge NeuroWorks announces a new UK-wide initiative designed to power high-risk, high-impact experimentation in early-stage neurotechnology.
Beta Launch of LYEONS Heart
The Beta Launch of 23 LYEONS Heart devices is now live!
VALANX Biotech establishes Board of Directors
Renowned industry leaders, Michael Boehler, Alexander Schwartz, Urs Spitz and Ingo Nagler, appointed to guide strategic and commercial development
